Table 4.
Effects of intervention with placebo and PVE on hematology parameters in obese subjects (Data are shown as means ± standard deviation)
| Normal value | Placebo (n = 58) | PVE (n = 56) | |||||
|---|---|---|---|---|---|---|---|
| Baseline | 35 Days | p Value | Baseline | 35 Days | p Value | ||
| Red blood cell (*1012/L) | 3.5–5.0 | 4.89 ± 0.37 | 4.75 ± 0.75 | >.05 | 4.79 ± 0.53 | 4.82 ± 0.45 | >.05 |
| White blood cell (*109/L) | 3.5–9.7 | 5.92 ± 1.27 | 5.76 ± 1.67 | >.05 | 5.99 ± 1.39 | 6.20 ± 1.51 | >.05 |
| Hemoglobin (g/L) | 110–160 | 145.0 ± 10.3 | 138.8 ± 11.0 | >.05 | 140.9 ± 22.0 | 139.0 ± 10.1 | >.05 |
| Platelet (*109/L) | 100–400 | 205.0 ± 53.1 | 202.4 ± 55.9 | >.05 | 205.1 ± 46.5 | 209.6 ± 49.5 | >.05 |